Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Pneumothorax-I01:26

Pneumothorax-I

177
A pneumothorax is a condition where air builds up in the space between the lung and the chest wall, causing the lung to collapse. This condition arises when air enters the space between the parietal and visceral pleura, disrupting the negative pressure essential for lung inflation. This can lead to a partial or complete collapse of the lung.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
177
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

214
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
214
Esophageal Perforation-I: Introduction01:22

Esophageal Perforation-I: Introduction

76
Esophageal perforation is a severe medical condition characterized by a breach in the integrity of the esophageal wall. This breach can occur due to various factors such as trauma, medical procedures, or underlying diseases. When the esophageal wall is compromised, it allows food, fluids, and digestive juices into the chest cavity or adjacent structures, leading to potential complications and health risks.
The location of esophageal perforation can vary, occurring anywhere along the esophagus....
76
Esophageal Perforation-II: Clinical Manifestations and Management01:28

Esophageal Perforation-II: Clinical Manifestations and Management

53
Esophageal perforations manifest in various clinical forms, influenced by factors such as the perforation's cause and location (cervical, intrathoracic, or intra-abdominal), the extent of contamination, and potential injury to adjacent mediastinal structures. The timing between the perforation occurrence and treatment initiation also affects the clinical presentation.
Clinical Manifestations:
53
Pneumothorax-II01:27

Pneumothorax-II

127
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
127
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

235
The pathophysiology of pneumonia involves the following steps:
235

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Outcome and factors affecting prognosis in treat and extend treatment for neovascular age-related macular degeneration-a real world study.

BMC ophthalmology·2026
Same author

Risk Factors for Primary Sclerosing Cholangitis Recurrence Following Liver Transplantation: A Multicenter Retrospective Analysis.

Clinical transplantation·2026
Same author

Nutritional status and surgical outcomes in patients with esophageal atresia: findings from Turkish Esophageal Atresia Registry.

Pediatric surgery international·2025
Same author

CD20+ natural killer cells are polyfunctional, memory-like cells that are enriched in inflammatory disorders.

Journal of immunology (Baltimore, Md. : 1950)·2025
Same author

Pre-transplant predictors of 3-Month survival following liver transplantation for acute liver failure in adult and pediatric patients in Türkiye.

Scientific reports·2025
Same author

Experience with stem cell therapy in neonates: Hope or disappointment?

Early human development·2025

相关实验视频

Updated: Jun 14, 2025

Author Spotlight: Enhancing Understanding and Treatment Strategies with the NEC-on-a-Chip Model
06:51

Author Spotlight: Enhancing Understanding and Treatment Strategies with the NEC-on-a-Chip Model

Published on: July 28, 2023

1.2K

肺炎肠道病:它总是表示死性肠球炎吗?

Yeşim Coşkun1, Mehmet Ali Özen2, Kalender Kayaş1

  • 1Department of Pediatrics, Koç University Hospital, İstanbul, Türkiye.

The Turkish journal of pediatrics
|January 14, 2025
PubMed
概括

新生儿的肺炎肠道 (PI) 可能表明牛奶蛋白质过敏 (CMA),而不仅仅是死性肠球炎 (NEC). 早期诊断和管理CMA可以预防复发的NEC类症状.

关键词:
牛奶蛋白质过敏 牛奶蛋白质过敏死性肠球炎 (necrotizing enterocolitis) 是一种致死性肠球炎的疾病.这是新生儿新生儿.肺炎症是肠道性肺炎.

更多相关视频

A Neonatal BALB/c Mouse Model of Necrotizing Enterocolitis
05:39

A Neonatal BALB/c Mouse Model of Necrotizing Enterocolitis

Published on: November 30, 2021

3.5K
Breast Milk Enhances Growth of Enteroids: An Ex Vivo Model of Cell Proliferation
09:02

Breast Milk Enhances Growth of Enteroids: An Ex Vivo Model of Cell Proliferation

Published on: February 15, 2018

19.4K

相关实验视频

Last Updated: Jun 14, 2025

Author Spotlight: Enhancing Understanding and Treatment Strategies with the NEC-on-a-Chip Model
06:51

Author Spotlight: Enhancing Understanding and Treatment Strategies with the NEC-on-a-Chip Model

Published on: July 28, 2023

1.2K
A Neonatal BALB/c Mouse Model of Necrotizing Enterocolitis
05:39

A Neonatal BALB/c Mouse Model of Necrotizing Enterocolitis

Published on: November 30, 2021

3.5K
Breast Milk Enhances Growth of Enteroids: An Ex Vivo Model of Cell Proliferation
09:02

Breast Milk Enhances Growth of Enteroids: An Ex Vivo Model of Cell Proliferation

Published on: February 15, 2018

19.4K

科学领域:

  • 新生儿医学 新生儿医学
  • 儿科胃肠病学 儿科胃肠病学
  • 放射学 放射学是一门学科.

背景情况:

  • 肠道肺炎 (PI) 是一种罕见的放射性发现,通常与新生儿死性肠球炎 (NEC) 有关.
  • 牛奶蛋白过敏 (CMA) 是婴儿常见的过敏,通常在食用基于牛奶的配方奶或通过母乳养后出现.

研究的目的:

  • 调查新生儿肺炎肠病 (PI) 和牛奶蛋白过敏 (CMA) 之间的关联.
  • 强调在PI的差异诊断中考虑CMA的重要性,与NEC一起.

主要方法:

  • 三名新生儿与PI一起出现的案例报告.
  • 临床评估,CMA和/或NEC的诊断,以及对基于氨基酸的配方的反应.
  • 与CMA相关的反复出现的PI和NEC类陈述的分析.

主要成果:

  • 有PI的三名新生儿被诊断出患有CMA和/或NEC.
  • 在开始使用基于氨基酸的配方后,观察到快速的临床改善和疾病不复发.
  • 两个病例被诊断为CMA,而一个病例的复发性NEC类发作也被怀疑与CMA有关.

结论:

  • 牛奶蛋白过敏 (CMA) 应考虑在新生儿肺炎肠道 (PI),除了死亡性肠球炎 (NEC).
  • 经常性NEC的管理协议应该包含CMA的策略.